Wird geladen...
Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor
Despite being one of the first antitubercular agents identified, isoniazid (INH) is still the most prescribed drug for prophylaxis and tuberculosis (TB) treatment and, together with rifampicin, the pillars of current chemotherapy. A high percentage of isoniazid resistance is linked to mutations in t...
Gespeichert in:
| Veröffentlicht in: | EBioMedicine |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4919555/ https://ncbi.nlm.nih.gov/pubmed/27428438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.05.006 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|